SHP2-IN-33
Product Specifications
CAS Number
2894017-46-8
Target
Phosphatase|||Apoptosis|||MAPK
Related Pathways
Apoptosis|||MAPK|||Metabolism
Bioactivity
SHP2-IN-33 (Compound D13) is an allosteric inhibitor of SHP2, exhibiting an IC50 of 1.2 ?M against SHP2. It demonstrates an antiproliferative IC50 of 38 ?M in Huh7 cells by blocking the G0/G1 cell cycle, inducing apoptosis (Apoptosis), and inhibiting the MAPK signaling pathway. In a Huh7 xenograft mouse model, SHP2-IN-33 shows significant antitumor activity and favorable pharmacokinetic properties, including 54% oral bioavailability and a half-life of 10.57 hours. SHP2-IN-33 holds potential for research involving SHP2-associated tumor diseases.
Smiles
ClC1=CC=CC(SC2=NC=C(N=C2N)N(C)C3CCNCC3)=C1Cl
Molecular Formula
C16H19Cl2N5S
Molecular Weight
384.33
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/296282250503258175/T203605
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6351539-01 0.1 mL
ST5, CT (ST5, DENND2B, HTS1, Suppression of tumorigenicity 5 protein, DENN domain-containing protein 2B, HeLa tumor suppression 1) (MaxLight 550)
Ask
View Details 
MBS6351539-02 5x 0.1 mL
ST5, CT (ST5, DENND2B, HTS1, Suppression of tumorigenicity 5 protein, DENN domain-containing protein 2B, HeLa tumor suppression 1) (MaxLight 550)
Ask
View Details